Cargando…
The Role of DLLs in Cancer: A Novel Therapeutic Target
Delta-like ligands (DLLs) control Notch signaling. DLL1, DLL3 and DLL4 are frequently deregulated in cancer and influence tumor growth, the tumor vasculature and tumor immunity, which play different roles in cancer progression. DLLs have attracted intense research interest as anti-cancer therapeutic...
Autores principales: | Xiu, Meng-Xi, Liu, Yuan-Meng, Kuang, Bo-hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213894/ https://www.ncbi.nlm.nih.gov/pubmed/32440154 http://dx.doi.org/10.2147/OTT.S244860 |
Ejemplares similares
-
Parental Acculturation and Children’s Bilingual Abilities: A Study With Chinese American and Mexican American Preschool DLLs
por: Uchikoshi, Yuuko, et al.
Publicado: (2022) -
CCR9 in cancer: oncogenic role and therapeutic targeting
por: Tu, Zhenbo, et al.
Publicado: (2016) -
The Complement System: A Potential Therapeutic Target in Liver Cancer
por: Yuan, Meng, et al.
Publicado: (2022) -
Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022) -
Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target
por: Tang, Lin, et al.
Publicado: (2020)